Home
About
Overview
Sharing Data
ORCID
Help
History (22)
Uridine Kinase
Carbenicillin
Urokinase-Type Plasminogen Activator
Thiamphenicol
Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.
Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Endometrioid
Chemotherapy, Adjuvant
Clinical Trials as Topic
Cohort Studies
Cytoreduction Surgical Procedures
Female
Humans
Middle Aged
Neoadjuvant Therapy
Neoplasm, Residual
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Neutropenia
Ovarian Neoplasms
Patient Selection
Peripheral Nervous System Diseases
Platinum Compounds
Retrospective Studies
Taxoids
Thrombocytopenia
Young Adult
authors with profiles
Kai Ding
Kathleen Moore